Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2013, Article ID 740837, 12 pages
http://dx.doi.org/10.1155/2013/740837
Case Report

Behçet’s Disease, Associated Large Vessel Thrombosis, and Coexistent Thrombophilia: A Distinct Nosological Entity?

1st Department of Internal Medicine, “Georgios Papanikolaou” General Hospital, Exochi, 570 10 Thessaloniki, Greece

Received 15 February 2013; Revised 22 May 2013; Accepted 10 June 2013

Academic Editor: Christos D. Lionis

Copyright © 2013 Dimitrios Stoimenis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Gül, “Behçet's disease as an autoinflammatory disorder,” Current Drug Targets, vol. 4, no. 1, pp. 81–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. International Study Group for Behçet's Disease, “Criteria for diagnosis of Behçet's disease,” The Lancet, vol. 335, no. 8697, pp. 1078–1080, 1990. View at Google Scholar
  3. M. S. Kurokawa and N. Suzuki, “Behcet's disease,” Clinical and Experimental Medicine, vol. 4, no. 1, pp. 10–20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Hayashi and N. Mizuki, “Ocular manifestations in Behçet's disease,” Japan Medical Association Journal, vol. 49, no. 7-8, pp. 260–268, 2006. View at Google Scholar · View at Scopus
  5. F. R. Rosendaal, “Venous thrombosis: the role of genes, environment, and behavior,” Hematology, vol. 2005, pp. 1–12, 2005. View at Google Scholar · View at Scopus
  6. M. Biggioggero and P. L. Meroni, “The geoepidemiology of the antiphospholipid antibody syndrome,” Autoimmunity Reviews, vol. 9, no. 5, pp. A299–A304, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. M. Jadaon, “Epidemiology of activated protein C resistance and factor V leiden mutation in the mediterranean region,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 3, no. 1, Article ID e2011037, 2011. View at Google Scholar
  8. A. Gül, U. Ozbek, C. Oztürk, M. Inanç, M. Koniçe, and T. Ozçelik, “Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease,” British Journal of Rheumatology, vol. 35, no. 11, pp. 1178–1180, 1996. View at Google Scholar
  9. A. Gül, A. B. Aslantas, T. Tekinay, M. Koniçe, and T. Ozçelik, “Procoagulant mutations and venous thrombosis in Behcet's disease,” Rheumatology, vol. 38, no. 12, pp. 1298–1299, 1999. View at Google Scholar · View at Scopus
  10. M. Silingardi, C. Salvarani, L. Boiardi et al., “Factor V leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis,” Arthritis Care and Research, vol. 51, no. 2, pp. 177–183, 2004. View at Google Scholar · View at Scopus
  11. N. Karakus, S. Yigit, G. Kalkan et al., “Association between the methylene tetrahydrofolate reductase gene C677T mutation and colchicine unresponsiveness in Behcet's disease,” Molecular Vision, vol. 18, pp. 1696–1700, 2012. View at Google Scholar
  12. J. M. Ricart, A. Vayá, J. Todolí et al., “Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events,” Journal of Thrombosis and Haemostasis, vol. 95, no. 4, pp. 618–624, 2006. View at Google Scholar
  13. F. Shahram, A. Faridar, M. G. Hamedani et al., “Plasma homocysteine level in patients with Behcet's disease with or without thrombosis,” Archives of Iranian Medicine, vol. 13, no. 6, pp. 476–481, 2010. View at Google Scholar · View at Scopus
  14. M. Leiba, U. Seligsohn, Y. Sidi et al., “Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease,” Annals of the Rheumatic Diseases, vol. 63, no. 11, pp. 1445–1449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Tokay, H. Direskeneli, S. Yurdakul, and T. Akoglu, “Anticardiolipin antibodies in Behçet's disease: a reassessment,” Rheumatology, vol. 40, no. 2, pp. 192–195, 2001. View at Google Scholar · View at Scopus
  16. R. G. Hull, E. N. Harris, and A. E. Gharavi, “Anticardiolipin antibodies: occurrence in Behcet's syndrome,” Annals of the Rheumatic Diseases, vol. 43, no. 5, pp. 746–748, 1984. View at Google Scholar · View at Scopus
  17. D.-K. Kim, S. N. C. Chang, D. Bang, E.-S. Lee, and S. Lee, “Clinical analysis of 40 cases of childhood-onset Behcet's disease,” Pediatric Dermatology, vol. 11, no. 2, pp. 95–101, 1994. View at Google Scholar · View at Scopus
  18. M. B. Owlia and G. Mehrpoor, “Behcet's disease: new concepts in cardiovascular involvements and future direction for treatment,” ISRN Pharmacology, vol. 2012, Article ID 760484, 2012. View at Publisher · View at Google Scholar
  19. R. Tunes and M. Santiago, “Behcet's syndrome: literature review,” Current Rheumatology Reviews, vol. 5, no. 1, pp. 64–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. F. A. Alnaimat and J. R. Lisse, “Behcet Disease,” Medscape, http://emedicine.medscape.com/article/329099-overview#a0199/.
  21. K. T. Calamia, F. C. Wilson, M. Icen, C. S. Crowson, S. E. Gabriel, and H. M. Kremers, “Epidemiology and clinical characteristics of behcet's disease in the us: a population-based study,” Arthritis Care and Research, vol. 61, no. 5, pp. 600–604, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Parentin, L. Lepore, I. Rabach, and S. Pensiero, “Paediatric Behcet's disease presenting with recurrent papillitis and episcleritis: a case report,” Journal of Medical Case Reports, vol. 5, p. 81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. H. Verity, G. R. Wallace, R. W. Vaughan, and M. R. Stanford, “Behçet's disease: from Hippocrates to the third millennium,” British Journal of Ophthalmology, vol. 87, no. 9, pp. 1175–1183, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Karasneh, A. Gül, W. E. Ollier, A. J. Silman, and J. Worthington, “Whole-genome screening for susceptibility genes in multicase families with Behçet's disease,” Arthritis and Rheumatism, vol. 52, no. 6, pp. 1836–1842, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Kaneko, A. Togashi, S. Saito et al., “Behçet's disease (Adamantiades-Behçet's disease),” Clinical and Developmental Immunology, vol. 2011, Article ID 681956, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Al-Araji and D. P. Kidd, “Neuro-Behçet's disease: epidemiology, clinical characteristics, and management,” The Lancet Neurology, vol. 8, no. 2, pp. 192–204, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. E. C. Ebert, “Gastrointestinal manifestations of behçet's Disease,” Digestive Diseases and Sciences, vol. 54, no. 2, pp. 201–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. C. Zouboulis, “Epidemiology of Adamantiades-Behcet's disease,” Annales de Medecine Interne, vol. 150, no. 6, pp. 488–498, 1999. View at Google Scholar · View at Scopus
  29. R. Sarica-Kucukoglu, A. Akdag-Kose, M. Kayabali et al., “Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases,” International Journal of Dermatology, vol. 45, no. 8, pp. 919–921, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Sağdiç, Z. G. Ozer, D. Saba, M. Türe, and M. Cengiz, “Venous lesions in Behçet's disease,” European Journal of Vascular and Endovascular Surgery, vol. 11, no. 4, pp. 437–440, 1996. View at Google Scholar
  31. F. Davatchi, F. Shahram, C. Chams-Davatchi et al., “Behcet's disease in Iran: analysis of 6500 cases,” International Journal of Rheumatic Diseases, vol. 13, no. 4, pp. 367–373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Ideguchi, A. Suda, M. Takeno, A. Ueda, S. Ohno, and Y. Ishigatsubo, “Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective cohort study,” Clinical and Experimental Rheumatology, vol. 29, no. 4, supplement 67, pp. S47–S53, 2011. View at Google Scholar · View at Scopus
  33. P. G. Kaklamanis and K. T. Calamia, “Behçet's disease: an update on pathogenesis, diagnosis and management of vascular involvement,” Rheumatology Reports, vol. 2, no. 1, pp. 13–25, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Cocco and A. Y. Gasparyan, “Behçet’s disease: an insight from a cardiologist’s point of view,” The Open Cardiovascular Medicine Journal, vol. 4, pp. 63–70, 2010. View at Google Scholar
  35. F. El Louali, A. Tamdy, A. Soufiani et al., “Cardiac thrombosis as a manifestation of Behçet syndrome,” Texas Heart Institute Journal, vol. 37, no. 5, pp. 568–571, 2010. View at Google Scholar · View at Scopus
  36. M. la Regina, A. Y. Gasparyan, F. Orlandini, and D. Prisco, “Behçet's disease as a model of venous thrombosis,” Open Cardiovascular Medicine Journal, vol. 4, no. 1, pp. 71–77, 2010. View at Google Scholar · View at Scopus
  37. M. M. Jadaon, “Epidemiology of prothrombin G20210A mutation in the mediterranean region,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 3, no. 1, Article ID e2011054, 2011. View at Google Scholar
  38. N. Irani-Hakime, H. Tamim, R. Kreidy, and W. Y. Almawi, “The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese,” American Journal of Hematology, vol. 65, no. 1, pp. 45–49, 2000. View at Google Scholar
  39. A. Hamdan, W. Mansour, I. Uthman, A. F. Masri, F. Nasr, and T. Arayssi, “Behçet's disease in Lebanon: clinical profile, severity and two-decade comparison,” Clinical Rheumatology, vol. 25, no. 3, pp. 364–367, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Espinosa, J. Font, D. Tàssies et al., “Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin,” American Journal of Medicine, vol. 112, no. 1, pp. 37–43, 2002. View at Publisher · View at Google Scholar
  41. H. Yazici, S. Ugurlu, and E. Seyahi, “Behçet syndrome: is it one condition?” Clinical Reviews in Allergy & Immunology, vol. 43, no. 3, pp. 275–280, 2012. View at Google Scholar
  42. P. C. Phillips, “Epistasis—the essential role of gene interactions in the structure and evolution of genetic systems,” Nature Reviews Genetics, vol. 9, no. 11, pp. 855–867, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Zöller, X. Li, J. Sundquist, and K. Sundquist, “Autoimmune diseases and venous thromboembolism: a review of the literature,” American Journal of Cardiovascular Disease, vol. 2, no. 3, pp. 171–183, 2012. View at Google Scholar
  44. M. J. Hickey and P. Kubes, “Intravascular immunity: the host-pathogen encounter in blood vessels,” Nature Reviews Immunology, vol. 9, no. 5, pp. 364–375, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Engelmann and S. Massberg, “Thrombosis as an intravascular effector of innate immunity,” Nature Reviews Immunology, vol. 13, no. 1, pp. 34–45, 2013. View at Google Scholar